GLP-1 medications have a whole host of bizarre side effects, but a new study suggests one that impacts the way food tastes
Hence an approval in the next one-and-a-half to two years seems unlikely." Chereddi adds, "Hengrui's product is just starting Phase 3 in China, and Innovent's product has approval from the Chinese FDA, but hasn't been filed in India." His conclusion: "Indian generic manufacturers face a limited but real opportunitynot an open market." Shah frames it as a "timing risk, not an inevitability", and flags three gating factors beyond trial requirements: Regulatory scrutiny of novel oral delivery systems, bioavailability concerns specific to Indian populations and intellectual property protection on oral peptide platforms that limits immediate generic replication
Stool Quality & Constipation Strangely, reducing or eliminating fiber resolved chronic constipation, as well as the pain, bloating, and bleeding associated with it, in two studies with a total of 779 participants [45, 46]
They show decreased activation in brain regions associated with cravings when patients are on GLP-1 therapies